{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:46:45Z","timestamp":1783637205945,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T00:00:00Z","timestamp":1534377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Womens Ment Health"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00737-018-0905-3","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T04:59:18Z","timestamp":1534395558000},"page":"383-390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Antidepressants in breast milk; comparative analysis of excretion ratios"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3851-4117","authenticated-orcid":false,"given":"Georgios","family":"Schoretsanitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Sa\u00dfmannshausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordula","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Gr\u00fcnder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Paulzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,16]]},"reference":[{"issue":"Suppl 1","key":"905_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/00004850-199603001-00002","volume":"11","author":"P Baumann","year":"1996","unstructured":"Baumann P (1996) Pharmacology and pharmacokinetics of citalopram and other SSRIs. Int Clin Psychopharmacol 11(Suppl 1):5\u201311","journal-title":"Int Clin Psychopharmacol"},{"key":"905_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-2125.1992.tb04077.x","volume":"33","author":"EJ Begg","year":"1992","unstructured":"Begg EJ, Atkinson HC, Duffull SB (1992) Prospective evaluation of a model for the prediction of milk: plasma drug concentrations from physicochemical characteristics. Br J Clin Pharmacol 33:501\u2013505","journal-title":"Br J Clin Pharmacol"},{"key":"905_CR3","volume-title":"Drugs and human lactation","author":"PN Bennett","year":"1996","unstructured":"Bennett PN (1996) Drugs and human lactation. Elsevier, Amsterdam"},{"key":"905_CR4","doi-asserted-by":"publisher","unstructured":"Berard A, Zhao JP, Sheehy O (2017) Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. BMJ Open 7(1):e013372. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2016-013372","DOI":"10.1136\/bmjopen-2016-013372"},{"key":"905_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/157340411794474784","volume":"7","author":"JO Berle","year":"2011","unstructured":"Berle JO, Spigset O (2011) Antidepressant use during breastfeeding. Curr Womens Health Rev 7:28\u201334","journal-title":"Curr Womens Health Rev"},{"key":"905_CR6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.4088\/JCP.v65n0911","volume":"65","author":"JO Berle","year":"2004","unstructured":"Berle JO, Steen VM, Aamo TO, Breilid H, Zahlsen K, Spigset O (2004) Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes. J Clin Psychiatry 65:1228\u20131234","journal-title":"J Clin Psychiatry"},{"key":"905_CR7","first-page":"241","volume":"25","author":"K Bezchlibnyk-Butler","year":"2000","unstructured":"Bezchlibnyk-Butler K, Aleksic I, Kennedy SH (2000) Citalopram--a review of pharmacological and clinical effects. J Psychiatry Neurosci 25:241\u2013254","journal-title":"J Psychiatry Neurosci"},{"key":"905_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jchromb.2005.09.034","volume":"829","author":"J Bhatt","year":"2005","unstructured":"Bhatt J, Jangid A, Venkatesh G, Subbaiah G, Singh S (2005) Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 829:75\u201381","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"905_CR9","first-page":"89","volume":"3","author":"I Brockington","year":"2004","unstructured":"Brockington I (2004) Diagnosis and management of post-partum disorders: a review. World Psychiatry 3:89\u201395","journal-title":"World Psychiatry"},{"key":"905_CR10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1176\/appi.ajp.158.7.1001","volume":"158","author":"VK Burt","year":"2001","unstructured":"Burt VK, Suri R, Altshuler L, Stowe Z, Hendrick VC, Muntean E (2001) The use of psychotropic medications during breast-feeding. Am J Psychiatry 158:1001\u20131009","journal-title":"Am J Psychiatry"},{"key":"905_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.4088\/JCP.v62n0803","volume":"62","author":"LS Cohen","year":"2001","unstructured":"Cohen LS, Viguera AC, Bouffard SM, Nonacs RM, Morabito C, Collins MH et al (2001) Venlafaxine in the treatment of postpartum depression. J Clin Psychiatry 62:592\u2013596","journal-title":"J Clin Psychiatry"},{"key":"905_CR12","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2165\/00003088-200241150-00002","volume":"41","author":"CL Devane","year":"2002","unstructured":"Devane CL, Liston HL, Markowitz JS (2002) Clinical pharmacokinetics of sertraline. Clin Pharmacokinet 41:1247\u20131266","journal-title":"Clin Pharmacokinet"},{"key":"905_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2165\/00023210-200620030-00002","volume":"20","author":"M Eberhard-Gran","year":"2006","unstructured":"Eberhard-Gran M, Eskild A, Opjordsmoen S (2006) Use of psychotropic medications in treating mood disorders during lactation: practical recommendations. CNS Drugs 20:187\u2013198","journal-title":"CNS Drugs"},{"key":"905_CR14","doi-asserted-by":"crossref","unstructured":"Eke AC, Saccone G, Berghella V (2016) Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis. BJOG 123(12):1900\u20131907","DOI":"10.1111\/1471-0528.14144"},{"key":"905_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.ftd.0000187972.02624.2e","volume":"28","author":"EJ Franssen","year":"2006","unstructured":"Franssen EJ, Meijs V, Ettaher F, Valerio PG, Keessen M, Lameijer W (2006) Citalopram serum and milk levels in mother and infant during lactation. Ther Drug Monit 28:2\u20134","journal-title":"Ther Drug Monit"},{"key":"905_CR16","doi-asserted-by":"crossref","unstructured":"Gentile S (2005) The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf 28(2):137\u201352","DOI":"10.2165\/00002018-200528020-00005"},{"key":"905_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2165\/00002018-200730020-00002","volume":"30","author":"S Gentile","year":"2007","unstructured":"Gentile S (2007) Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index. Drug Saf 30:107\u2013121","journal-title":"Drug Saf"},{"key":"905_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1067\/mcp.2002.126181","volume":"72","author":"T Heikkinen","year":"2002","unstructured":"Heikkinen T, Ekblad U, Kero P, Ekblad S, Laine K (2002) Citalopram in pregnancy and lactation. Clin Pharmacol Ther 72:184\u2013191","journal-title":"Clin Pharmacol Ther"},{"key":"905_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4088\/JCP.v64n0409","volume":"64","author":"V Hendrick","year":"2003","unstructured":"Hendrick V, Smith LM, Hwang S, Altshuler LL, Haynes D (2003) Weight gain in breastfed infants of mothers taking antidepressant medications. J Clin Psychiatry 64:410\u2013412","journal-title":"J Clin Psychiatry"},{"key":"905_CR20","doi-asserted-by":"crossref","unstructured":"Hiemke, C., Bergemann, N., Clement, H. W., Conca, A., Deckert, J., Domschke, K., et al. 2017. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry","DOI":"10.1055\/s-0043-116492"},{"issue":"1-02","key":"905_CR21","first-page":"e1","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K et al (2018) Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 51(1-02):e1","journal-title":"Pharmacopsychiatry"},{"key":"905_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1046\/j.1365-2125.1998.00710.x","volume":"45","author":"KF Ilett","year":"1998","unstructured":"Ilett KF, Hackett LP, Dusci LJ, Roberts MJ, Kristensen JH, Paech M et al (1998) Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Br J Clin Pharmacol 45:459\u2013462","journal-title":"Br J Clin Pharmacol"},{"key":"905_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/00007691-199704000-00021","volume":"19","author":"PN Jensen","year":"1997","unstructured":"Jensen PN, Olesen OV, Bertelsen A, Linnet K (1997) Citalopram and desmethylcitalopram concentrations in breast milk and in serum of mother and infant. Ther Drug Monit 19:236\u2013239","journal-title":"Ther Drug Monit"},{"key":"905_CR24","first-page":"B4916","volume":"61","author":"E Jimenez-Solem","year":"2014","unstructured":"Jimenez-Solem E (2014) Exposure to antidepressants during pregnancy--prevalences and outcomes. Dan Med J 61:B4916","journal-title":"Dan Med J"},{"issue":"10","key":"905_CR25","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3390\/ph6101221","volume":"6","author":"B Kallen","year":"2013","unstructured":"Kallen B, Borg N, Reis M (2013) The use of central nervous system active drugs during pregnancy. Pharmaceuticals (Basel) 6(10):1221\u20131286. \n                    https:\/\/doi.org\/10.3390\/ph6101221","journal-title":"Pharmaceuticals (Basel)"},{"key":"905_CR26","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/j.1552-4604.1992.tb03875.x","volume":"32","author":"KJ Klamerus","year":"1992","unstructured":"Klamerus KJ, Maloney K, Rudolph RL, Sisenwine SF, Jusko WJ, Chiang ST (1992) Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite. J Clin Pharmacol 32:716\u2013724","journal-title":"J Clin Pharmacol"},{"key":"905_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1046\/j.1365-2125.1998.00705.x","volume":"45","author":"JH Kristensen","year":"1998","unstructured":"Kristensen JH, Ilett KF, Dusci LJ, Hackett LP, Yapp P, Wojnar-Horton RE et al (1998) Distribution and excretion of sertraline and N-desmethylsertraline in human milk. Br J Clin Pharmacol 45:453\u2013457","journal-title":"Br J Clin Pharmacol"},{"key":"905_CR28","doi-asserted-by":"crossref","unstructured":"Laine K, Heikkinen T, Ekblad U, Kero P (2003) Effects of exposure to selective serotonin reuptakers inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 60(7):720\u2013726","DOI":"10.1001\/archpsyc.60.7.720"},{"key":"905_CR29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/GRF.0b013e3181b52bd6","volume":"52","author":"T Lanza Di Scalea","year":"2009","unstructured":"Lanza Di Scalea T, Wisner KL (2009) Antidepressant medication use during breastfeeding. Clin Obstet Gynecol 52:483\u2013497","journal-title":"Clin Obstet Gynecol"},{"key":"905_CR30","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0002-9378(03)00868-8","volume":"190","author":"A Lee","year":"2004","unstructured":"Lee A, Woo J, Ito S (2004) Frequency of infant adverse events that are associated with citalopram use during breast-feeding. Am J Obstet Gynecol 190:218\u2013221","journal-title":"Am J Obstet Gynecol"},{"key":"905_CR31","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/01.jcp.0000236656.70544.f3","volume":"26","author":"S Misri","year":"2006","unstructured":"Misri S, Corral M, Wardrop AA, Kendrick K (2006) Quetiapine augmentation in lactation: a series of case reports. J Clin Psychopharmacol 26:508\u2013511","journal-title":"J Clin Psychopharmacol"},{"key":"905_CR32","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2165\/00002018-200225130-00002","volume":"25","author":"S Misri","year":"2002","unstructured":"Misri S, Kostaras X (2002) Benefits and risks to mother and infant of drug treatment for postnatal depression. Drug Saf 25:903\u2013911","journal-title":"Drug Saf"},{"key":"905_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1089\/bfm.2012.0084","volume":"8","author":"MJ M\u00fcller","year":"2013","unstructured":"M\u00fcller MJ, Preuss C, Paul T, Streit F, Brandhorst G, Seeliger S (2013) Serotonergic overstimulation in a preterm infant after sertraline intake via breastmilk. Breastfeed Med 8:327\u2013329","journal-title":"Breastfeed Med"},{"key":"905_CR34","volume-title":"Handbook of female Psychophamacology","author":"I Nulman","year":"2003","unstructured":"Nulman I, Ito S, Koren G (2003) Handbook of female Psychophamacology. Taylor & Francis, London"},{"key":"905_CR35","doi-asserted-by":"crossref","unstructured":"Ornoy A, Koren G (2017) Selective serotonin reuptake inhibitors during pregnancy: do we have now more definite answers related to prenatal exposure? Birth Defects Res 109(12):898\u2013908","DOI":"10.1002\/bdr2.1078"},{"key":"905_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2017.01.019","volume":"212","author":"M Paulzen","year":"2017","unstructured":"Paulzen M, Goecke TW, Stickeler E, Grunder G, Schoretsanitis G (2017a) Sertraline in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood. J Affect Disord 212:1\u20136","journal-title":"J Affect Disord"},{"key":"905_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pnpbp.2017.06.030","volume":"79","author":"M Paulzen","year":"2017","unstructured":"Paulzen M, Goecke TW, Stingl JC, Janssen G, Stickeler E, Gr\u00fcnder G et al (2017b) Pregnancy exposure to citalopram - therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood. Prog Neuro-Psychopharmacol Biol Psychiatry 79:213\u2013219","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"905_CR38","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1176\/appi.ajp.2007.07030390","volume":"164","author":"JL Payne","year":"2007","unstructured":"Payne JL (2007) Antidepressant use in the postpartum period: practical considerations. Am J Psychiatry 164:1329\u20131332","journal-title":"Am J Psychiatry"},{"key":"905_CR39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00737-006-0145-9","volume":"9","author":"TB Pearlstein","year":"2006","unstructured":"Pearlstein TB, Zlotnick C, Battle CL, Stuart S, O'hara MW, Price AB et al (2006) Patient choice of treatment for postpartum depression: a pilot study. Arch Womens Ment Health 9:303\u2013308","journal-title":"Arch Womens Ment Health"},{"issue":"Suppl","key":"905_CR40","first-page":"14","volume":"54","author":"SH Preskorn","year":"1993","unstructured":"Preskorn SH (1993) Pharmacokinetics of antidepressants: why and how they are relevant to treatment. J Clin Psychiatry 54(Suppl):14\u201334 discussion 55-6","journal-title":"J Clin Psychiatry"},{"key":"905_CR41","volume-title":"Clinical pharmacology of SSRI's","author":"SH Preskorn","year":"1996","unstructured":"Preskorn SH (1996) Clinical pharmacology of SSRI's. Okla, Professional Communications, Inc., Caddo"},{"key":"905_CR42","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/hup.599","volume":"19","author":"M Reis","year":"2004","unstructured":"Reis M, Aberg-Wistedt A, Agren H, Hoglund P, Akerblad AC, Bengtsson F (2004) Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression. Hum Psychopharmacol 19:283\u2013291","journal-title":"Hum Psychopharmacol"},{"key":"905_CR43","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0006-3223(99)00155-9","volume":"47","author":"K Schmidt","year":"2000","unstructured":"Schmidt K, Olesen OV, Jensen PN (2000) Citalopram and breast-feeding: serum concentration and side effects in the infant. Biol Psychiatry 47:164\u2013165","journal-title":"Biol Psychiatry"},{"key":"905_CR44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2710.2006.00763.x","volume":"31","author":"ME Shams","year":"2006","unstructured":"Shams ME, Arneth B, Hiemke C, Dragicevic A, Muller MJ, Kaiser R et al (2006) CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine. J Clin Pharm Ther 31:493\u2013502","journal-title":"J Clin Pharm Ther"},{"key":"905_CR45","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1046\/j.1365-2125.1997.t01-1-00576.x","volume":"44","author":"O Spigset","year":"1997","unstructured":"Spigset O, Carieborg L, Ohman R, Norstrom A (1997) Excretion of citalopram in breast milk. Br J Clin Pharmacol 44:295\u2013298","journal-title":"Br J Clin Pharmacol"},{"key":"905_CR46","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1176\/ajp.154.9.1255","volume":"154","author":"ZN Stowe","year":"1997","unstructured":"Stowe ZN, Owens MJ, Landry JC, Kilts CD, Ely T, Llewellyn A et al (1997) Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry 154:1255\u20131260","journal-title":"Am J Psychiatry"},{"key":"905_CR47","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04332.x","volume":"74","author":"SHL Thomas","year":"2012","unstructured":"Thomas SHL, Yates LM (2012) Prescribing without evidence - pregnancy. Br J Clin Pharmacol 74:691\u2013697","journal-title":"Br J Clin Pharmacol"},{"key":"905_CR48","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/j.1552-4604.1997.tb04270.x","volume":"37","author":"SM Troy","year":"1997","unstructured":"Troy SM, Parker VP, Hicks DR, Pollack GM, Chiang ST (1997) Pharmacokinetics and effect of food on the bioavailability of orally administered venlafaxine. J Clin Pharmacol 37:954\u2013961","journal-title":"J Clin Pharmacol"},{"key":"905_CR49","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1176\/appi.ajp.161.6.1066","volume":"161","author":"AM Weissman","year":"2004","unstructured":"Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL et al (2004) Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry 161:1066\u20131078","journal-title":"Am J Psychiatry"},{"key":"905_CR50","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1592\/phco.25.3.411.61597","volume":"25","author":"DH Whitby","year":"2005","unstructured":"Whitby DH, Smith KM (2005) The use of tricyclic antidepressants and selective serotonin reuptake inhibitors in women who are breastfeeding. Pharmacotherapy 25:411\u2013425","journal-title":"Pharmacotherapy"},{"key":"905_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/01.jcp.0000227706.56870.dd","volume":"26","author":"KL Wisner","year":"2006","unstructured":"Wisner KL, Hanusa BH, Perel JM, Peindl KS, Piontek CM, Sit DK et al (2006) Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol 26:353\u2013360","journal-title":"J Clin Psychopharmacol"}],"container-title":["Archives of Women's Mental Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-018-0905-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00737-018-0905-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-018-0905-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T05:14:23Z","timestamp":1567055663000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00737-018-0905-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,16]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["905"],"URL":"https:\/\/doi.org\/10.1007\/s00737-018-0905-3","relation":{},"ISSN":["1434-1816","1435-1102"],"issn-type":[{"value":"1434-1816","type":"print"},{"value":"1435-1102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,16]]},"assertion":[{"value":"2 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained by all patients participating in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Gerhard Gr\u00fcnder has served as a consultant for Boehringer Ingelheim (Ingelheim, Germany), Cheplapharm (Greifswald, Germany), Eli Lilly (Indianapolis, Ind, USA), Lundbeck (Copenhagen, Denmark), Ono Pharmaceuticals (Osaka, Japan), Roche (Basel, Switzerland), Servier (Paris, France), and Takeda (Osaka, Japan). He has served on the speakers\u2019 bureau of Eli Lilly, Gedeon Richter (Budapest, Hungary), Janssen Cilag (Neuss, Germany), Lundbeck, Roche, Servier, and Trommsdorf (Aachen, Germany). He has received grant support from Boehringer Ingelheim and Roche. He is co-founder of Pharma Image GmbH (D\u00fcsseldorf, Germany) and Brainfoods UG (Selfkant, Germany). Georgios Schoretsanitis received a grant from the bequest \u201cin memory of Maria Zaoussi,\u201d State Scholarships Foundation, Greece, for clinical research in Psychiatry for the academic year 2015\u20132016. The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}